Skip to Main Content

Paper Details

Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancer.
Cancer Gene Ther
12
2022
Author NameAffiliation
Shekhar GhamandeAugusta University
  • 1 - 1

Datasets

Release 1.2